Tradewinds Capital Management »

Ovid Therapeutics shares owned by Tradewinds Capital Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Tradewinds Capital Management from 13F filings

Historical chart of Tradewinds Capital Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Tradewinds Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Tradewinds Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $163 100 1.63

More positions owned by Tradewinds Capital Management

Abrdn Silver Etf Trust Physcl Silvr Shs (SIVR)
World Gold Tr Spdr Gld Minis (GLDM)
Select Sector Spdr Tr State Street Tec (XLK)
Spdr Series Trust State Street Spd (SPYG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Msci Sth Kor Etf (EWY)
Ishares Msci Spain Etf (EWP)
Spdr Series Trust State Street Spd (SPBO)
Ishares Tr Conv Bd Etf (ICVT)
Ishares Msci Italy Etf (EWI)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Schwab Strategic Tr Intl Eqty Etf (SCHF)

View all positions for Tradewinds Capital Management

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company
Geode Capital Management

View all funds holding Ovid Therapeutics